By
Latest Stories
Don’t miss our hot and upcoming stories
Can Ottai’s New AI Biosensor Reshape Chronic Disease Management for Millions?
AI-powered wearable from Oxford-founded Ottai offers real-time insights, personalized support, and voice-driven healthcare experience Key…
Accelerating Drug Discovery with Artificial Intelligence: Strategic Insights from Pharma’s Biggest AI Alliances
Executive SummaryThe convergence of artificial intelligence (AI) and drug discovery is a strategic imperative. Pharmaceutical…
Is Merck’s WINREVAIR Set to Redefine First-Year PAH Treatment? Phase 3 HYPERION Results Show Over 70% Clinical Event Risk Reduction in Newly Diagnosed Patients
Key Takeaways:• Game-Changing Efficacy: WINREVAIR™ (sotatercept-csrk) cut clinical worsening risk in PAH by a statistically…
Can Sanofi’s Sarclisa-VRd Regimen, Backed by EMA’s CHMP, Redefine Frontline Standards in Transplant-Eligible Multiple Myeloma?
Key Highlights EMA’s CHMP Endorses Sarclisa-VRd for Frontline Multiple Myeloma in Transplant-Eligible AdultsOn June 23,…